Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Routine anticoagulation for venous thromboembolism prevention following laparoscopic gastric bypass.

Frantzides CT, Welle SN, Ruff TM, Frantzides AT.

JSLS. 2012 Jan-Mar;16(1):33-7. doi: 10.4293/108680812X13291597716906.

2.

Pharmacologic prophylaxis against venous thromboembolic complications is not mandatory for all laparoscopic Roux-en-Y gastric bypass procedures.

Clements RH, Yellumahanthi K, Ballem N, Wesley M, Bland KI.

J Am Coll Surg. 2009 May;208(5):917-21; discussion 921-3. doi: 10.1016/j.jamcollsurg.2009.01.034.

PMID:
19476861
3.

Enoxaparin thromboprophylaxis in gastric bypass patients: extended duration, dose stratification, and antifactor Xa activity.

Borkgren-Okonek MJ, Hart RW, Pantano JE, Rantis PC Jr, Guske PJ, Kane JM Jr, Gordon N, Sambol NC.

Surg Obes Relat Dis. 2008 Sep-Oct;4(5):625-31. doi: 10.1016/j.soard.2007.11.010. Epub 2008 Feb 8.

PMID:
18261965
4.

Incidence of clinically evident deep venous thrombosis after laparoscopic Roux-en-Y gastric bypass.

Gonzalez QH, Tishler DS, Plata-Munoz JJ, Bondora A, Vickers SM, Leath T, Clements RH.

Surg Endosc. 2004 Jul;18(7):1082-4. Epub 2004 May 27.

PMID:
15156394
5.

The effect of extended post-discharge chemical thromboprophylaxis on venous thromboembolism rates after bariatric surgery: a prospective comparison trial.

Raftopoulos I, Martindale C, Cronin A, Steinberg J.

Surg Endosc. 2008 Nov;22(11):2384-91. doi: 10.1007/s00464-008-0031-9. Epub 2008 Jul 12.

PMID:
18622558
6.

Prophylactic inferior vena cava filters in high-risk bariatric surgery.

Vaziri K, Devin Watson J, Harper AP, Lee J, Brody FJ, Sarin S, Ignacio EA, Chun A, Venbrux AC, Lin PP.

Obes Surg. 2011 Oct;21(10):1580-4. doi: 10.1007/s11695-010-0301-1.

PMID:
21088928
7.

Duration of surgery independently influences risk of venous thromboembolism after laparoscopic bariatric surgery.

Chan MM, Hamza N, Ammori BJ.

Surg Obes Relat Dis. 2013 Jan-Feb;9(1):88-93. doi: 10.1016/j.soard.2011.09.019. Epub 2011 Oct 6.

PMID:
22055389
8.

Retrospective evaluation of venous thromboembolism prophylaxis in the adult cancer population.

Reeves D, Liu CY.

J Oncol Pharm Pract. 2010 Mar;16(1):27-31. doi: 10.1177/1078155209104379. Epub 2009 Apr 28.

PMID:
19401307
9.

Preoperative enoxaparin is safe to use in major gynecologic surgery for prophylaxis of venous thromboembolism: a retrospective cohort study.

Martino MA, George JG, Chen CC, Galic V, Kapoor R, Murray KC, Shubella J, Riker E, Lancaster JM, Hoffman MS.

Int J Gynecol Cancer. 2012 May;22(4):681-5. doi: 10.1097/IGC.0b013e3182454499.

PMID:
22343972
10.

Efficacy of venous thromboembolism prophylaxis in morbidly obese patients undergoing gastric bypass surgery.

Cotter SA, Cantrell W, Fisher B, Shopnick R.

Obes Surg. 2005 Oct;15(9):1316-20.

PMID:
16259895
11.

Economic and clinical evaluation of fondaparinux vs. enoxaparin for thromboprophylaxis following general surgery.

Farias-Eisner R, Horblyuk R, Franklin M, Lunacsek OE, Happe LE.

Curr Med Res Opin. 2009 May;25(5):1081-7. doi: 10.1185/03007990902837117 .

PMID:
19298219
12.

Venous thromboembolism prophylaxis for medical service-mostly cancer-patients at hospital discharge.

Fanikos J, Rao A, Seger AC, Piazza G, Catapane E, Chen X, Goldhaber SZ.

Am J Med. 2011 Dec;124(12):1143-50. doi: 10.1016/j.amjmed.2011.07.031.

PMID:
22114828
13.

Comparison of ximelagatran, an oral direct thrombin inhibitor, with enoxaparin for the prevention of venous thromboembolism following total hip replacement. A randomized, double-blind study.

Colwell CW Jr, Berkowitz SD, Davidson BL, Lotke PA, Ginsberg JS, Lieberman JR, Neubauer J, McElhattan JL, Peters GR, Francis CW.

J Thromb Haemost. 2003 Oct;1(10):2119-30.

14.

Prospective analysis of the incidence of deep venous thrombosis in bariatric surgery patients.

Prystowsky JB, Morasch MD, Eskandari MK, Hungness ES, Nagle AP.

Surgery. 2005 Oct;138(4):759-63; discussion 763-5.

PMID:
16269306
15.

Enoxaparin dose adjustment is associated with low incidence of venous thromboembolic events in acute burn patients.

Lin H, Faraklas I, Saffle J, Cochran A.

J Trauma. 2011 Dec;71(6):1557-61. doi: 10.1097/TA.0b013e31823070f9.

PMID:
22027887
16.

Cost and outcomes associated with rivaroxaban vs enoxaparin for the prevention of postsurgical venous thromboembolism from a US payer's perspective.

Duran A, Sengupta N, Diamantopoulos A, Forster F, Kwong L, Lees M.

J Med Econ. 2011;14(6):824-34. doi: 10.3111/13696998.2011.623203. Epub 2011 Oct 24.

PMID:
22023098
17.

Concurrent prophylactic placement of inferior vena cava filter in gastric bypass and adjustable banding operations in the Bariatric Outcomes Longitudinal Database.

Li W, Gorecki P, Semaan E, Briggs W, Tortolani AJ, D'Ayala M.

J Vasc Surg. 2012 Jun;55(6):1690-5. doi: 10.1016/j.jvs.2011.12.056. Epub 2012 Feb 22.

18.

Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery.

Agnelli G, Piovella F, Buoncristiani P, Severi P, Pini M, D'Angelo A, Beltrametti C, Damiani M, Andrioli GC, Pugliese R, Iorio A, Brambilla G.

N Engl J Med. 1998 Jul 9;339(2):80-5.

19.

Early venous thromboembolism prophylaxis with enoxaparin in patients with blunt traumatic brain injury.

Norwood SH, Berne JD, Rowe SA, Villarreal DH, Ledlie JT.

J Trauma. 2008 Nov;65(5):1021-6; discussion 1026-7. doi: 10.1097/TA.0b013e31818a0e74.

PMID:
19001969
Items per page

Supplemental Content

Write to the Help Desk